Semaglutide Weight Loss Timeline: What to Expect Week by Week (2026 Guide)

The Big Picture: What Clinical Trials Show

Before diving into the week-by-week specifics, it's essential to understand what the landmark clinical trials actually showed about weight loss timing on semaglutide.

The STEP-1 trial — the most comprehensive study of semaglutide 2.4mg (Wegovy) for weight loss — followed 1,961 adults over 68 weeks. The results were striking: participants lost an average of 14.9% of their body weight, compared to 2.4% in the placebo group.[1]

But perhaps more important than the final number is the shape of that weight loss curve. It's not linear. Weight loss is fastest in the first 16–20 weeks, slows considerably through months 5–9, and then reaches a near-plateau by month 12. Understanding this pattern prevents the discouragement that causes many people to quit just when the medication is working.

Weeks 1–4: The Starter Dose (0.25mg)

The first four weeks on semaglutide are deliberately underwhelming from a weight loss standpoint — and that's by design. The 0.25mg starter dose is a sub-therapeutic dose. Novo Nordisk designed it specifically to allow your gastrointestinal system to adjust to the medication, not to produce meaningful weight loss.

What you will likely notice during weeks 1–4:

• Reduced appetite: Many people report feeling full faster, noticing decreased food noise (the constant mental chatter about food), and feeling satisfied with smaller portions.
• Nausea: This is the most commonly reported side effect, affecting roughly 44% of STEP-1 participants. It typically peaks around weeks 2–4 and diminishes over time. See our complete side effects management guide for specific strategies.
• Minor weight change: Some people lose 1–3 lbs, mostly from reduced caloric intake. Others see no change at all on the scale — this is completely normal at this dose.
• Fatigue: Some people feel tired, particularly in the first 1–2 weeks. This typically resolves as the body adapts.

Weeks 5–8: Stepping Up to 0.5mg

At 0.5mg, most people start experiencing genuine appetite suppression for the first time. This is the dose where the "food noise" reduction becomes unmistakable for many — the constant preoccupation with food, cravings, and hunger that characterizes the experience of being overweight begins to quiet significantly.

Weight loss during weeks 5–8 is typically 0.5–1.5 lbs per week in the real world, depending on adherence to a calorie deficit and activity level. Clinical trial data suggests average weekly loss rates of approximately 0.3–0.6% of body weight at this stage.

Important timing note: when you jump from 0.25mg to 0.5mg, you may experience a temporary resurgence of nausea. This usually lasts 1–2 weeks and resolves. Eating smaller, low-fat meals and staying well hydrated (aim for 64–80 oz of water per day) significantly reduces this.

Weeks 9–12: Moving to 1.0mg

The jump to 1mg is often when people feel the medication's full effect for the first time. This is the maximum approved dose for Ozempic (for diabetes management), and clinical data from the SUSTAIN trials shows 10–12% body weight reduction at this dose over 68 weeks.

For Wegovy users continuing to 2.4mg, weeks 9–12 on 1mg are a preview of what's to come at higher doses. Many people lose their fastest rates of weight here — often 1–2 lbs per week when paired with dietary changes.

By week 12, a 220-lb person typically has lost 8–15 lbs depending on medication, starting weight, and lifestyle. Those who are very consistent with protein intake and some form of exercise tend to lose at the higher end of this range while preserving more muscle mass.

Weeks 13–16: The 1.7mg Step (Wegovy)

The 1.7mg step is unique to Wegovy's titration schedule. It serves as a bridge to the 2.4mg maintenance dose. Interestingly, some patients and providers find that 1.7mg provides excellent weight loss with fewer side effects than 2.4mg, making it a viable long-term dose for some individuals.

At this dose, you should be seeing cumulative weight loss of 10–20 lbs from your starting weight (for a 200+ lb person), with continued weekly losses. This is typically weeks 13–16, or about 3.5–4 months into treatment.

Weeks 17+: Maintenance at 2.4mg (Wegovy)

The 2.4mg maintenance dose is where the majority of Wegovy's clinical weight loss benefit occurs. In the STEP-1 trial, most of the 14.9% average weight loss accumulated over months 4–12 at this dose level.

What the timeline looks like from here:

• Months 4–6: Continued strong weight loss, often 1–1.5 lbs per week
• Months 6–9: Gradual slowdown to 0.5–1 lb per week as the body adapts
• Months 9–12: Weight loss continues but may slow to 0.25–0.5 lb per week
• Month 12+: Most people reach their nadir (lowest weight) somewhere between months 12–18

The Plateau: When Weight Loss Slows

The most emotionally difficult part of the semaglutide journey is the inevitable plateau. Almost everyone experiences it. Around months 8–12, the rate of weight loss slows dramatically. This is not the medication "stopping working" — it's a predictable physiological response.

Here's what's happening:

• Metabolic adaptation: As you lose weight, your resting metabolic rate (RMR) decreases. A lighter body burns fewer calories. The deficit that was easy to maintain early on becomes smaller as you lose weight.
• Compensation mechanisms: Your body activates hunger hormones (particularly ghrelin) in response to weight loss, partially counteracting semaglutide's appetite suppression.
• Reduced food noise suppression: Some people find that the dramatic reduction in food cravings they experienced at first becomes less pronounced over time — still better than without medication, but not as dramatic.

Plateau Management Strategies

• Increase protein: Add 20–30g of additional daily protein. This preserves muscle during calorie restriction and increases satiety.
• Audit your calories: After months on the medication, it's easy to return to old eating patterns without noticing. A brief period of food tracking often reveals a caloric creep.
• Add or intensify resistance training: Strength training increases muscle mass, which raises your resting metabolic rate and partially offsets metabolic adaptation.
• Discuss a dose check with your provider: In some cases, a dose adjustment or different injection timing may help.
• Don't confuse a plateau with failure: Weight stabilization after significant loss is normal. The body is defending its new lower weight.

Mounjaro and Zepbound: A Faster, Steeper Curve

Tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) follows a similar timeline structure but with steeper initial results. The SURMOUNT-1 trial showed average weight loss of 22.5% of body weight at the 15mg dose over 72 weeks.[2]

The titration also takes longer — starting at 2.5mg and stepping up to 15mg over 20 weeks — but the weight loss per week tends to be more dramatic once at therapeutic doses. Read our full Mounjaro vs Wegovy comparison for a detailed head-to-head analysis.

What Happens If You Stop?

This is perhaps the most important thing to understand about the semaglutide timeline: the weight loss is largely maintained only while on the medication. The SELECT trial and post-STEP extension studies showed that participants who discontinued semaglutide regained approximately two-thirds of their lost weight within one year of stopping.[3]

This is not a character flaw — it's biology. Semaglutide works by treating a chronic condition (obesity) that is driven by hormone dysregulation. Stopping the medication allows those hormones to return to their pre-treatment patterns.

This data underscores why most obesity medicine specialists now view GLP-1 medications as likely long-term treatments for many patients, not short-term interventions.

Realistic Expectations: A Summary Timeline

For a 220-lb person starting Wegovy (semaglutide 2.4mg), a realistic timeline looks something like this:

• Month 1 (0.25mg): 0–3 lbs lost. Focus is on tolerating the medication.
• Month 2 (0.5mg): 3–8 lbs total lost. Real appetite suppression begins.
• Month 3 (1.0mg): 8–15 lbs total lost. Fastest weekly losses begin.
• Month 4 (1.7mg): 12–20 lbs total lost.
• Month 5+ (2.4mg): 15–30+ lbs total lost by month 9.
• Month 9–12: Plateau phase. Cumulative loss may be 30–40+ lbs.
• Month 12–18: Weight nadir reached. Some patients continue to lose slowly.

Related Articles

• Semaglutide Dosage Guide: Complete Titration Schedule
• Managing Semaglutide Side Effects Week by Week
• Ozempic vs Wegovy: Which is Right for You?
• Mounjaro vs Wegovy: Full Comparison

References

1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
2. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
3. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide. Diabetes Obes Metab. 2022;24(8):1553-1564.